Zymeworks Inc 's Revenue in the fiscal year 2025 $ 105.97 millions
Zymeworks Inc 's Revenue in the fiscal year 2024 $ 76.30 millions
Zymeworks Inc 's Revenue in the fiscal year 2023 $ 76.01 millions
Zymeworks Inc 's Revenue in the fiscal year 2022 $ 412.48 millions
Zymeworks Inc 's Revenue in the fiscal year 2021 $ 26.68 millions
ZYME Revenue third quarter 2026 Y/Y Growth Comment
Zymeworks Inc achieved in the third quarter 2026, above Company average Revenue surge of 828.87% year on year, to $ 256.46 millions.
Looking into third quarter 2026 results within Major Pharmaceutical Preparations industry 57 other companies have achieved higher Revenue growth. While Zymeworks Inc ' s Revenue doubling of 828.87% ranks overall at the positon no. 530 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Zymeworks Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
54900 %
3112.14 %
-99.92 %
(Jun 30 2018)
ZYME's III. Quarter Q/Q Revenue Comment
Zymeworks Inc achieved in the III. Quarter 2026 above company average sequential Revenue doubling of 5487.36%, to $ 256.46 millions, from $4.59 millions in the second quarter. ZYME is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Major Pharmaceutical Preparations industry 25 other companies have achieved higher Revenue quarter on quarter growth. While Zymeworks Inc 's Revenue growth quarter on quarter, overall rank is 144.
Zymeworks Inc achieved in the III. Quarter 2026 above company average sequential Revenue doubling of 5487.36%, to $ 256.46 millions, from $4.59 millions in the second quarter. ZYME is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Major Pharmaceutical Preparations industry 25 other companies have achieved higher Revenue quarter on quarter growth. While Zymeworks Inc 's Revenue growth quarter on quarter, overall rank is 144.
Zymeworks Inc 's 12 Months Revenue Growth Year on Year
Zymeworks Inc 's cumulative 12 months Revenue continue to drop, but on the faster rate at -69.78% year on year, at Jun 30 2026 compare to the -12.98% decrease at Mar 31 2026. If the Zymeworks Inc 's fiscal year would end at Jun 30 2026, annual Revenue would be $37 millions.
In the Healthcare sector 48 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 165, from total ranking in previous quarter at 169.
Zymeworks Inc 's cumulative 12 months Revenue continue to drop, but on the faster rate at -69.78% year on year, at Jun 30 2026 compare to the -12.98% decrease at Mar 31 2026. If the Zymeworks Inc 's fiscal year would end at Jun 30 2026, annual Revenue would be $37 millions.
In the Healthcare sector 48 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 165, from total ranking in previous quarter at 169.
About Zymeworks Inc Revenue Growth Rates (ZYME), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
1,438.05%